Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Avacta Group (AVCT) Regulatory News

Date Source Headline
1st Feb 2021 7:00 am RNS AffyXell $7.3 Million Series A Financing
29th Jan 2021 11:00 am RNS Issue of Equity
28th Jan 2021 7:00 am RNS Collaboration Agreement with Bruker
7th Jan 2021 7:00 am RNS License Agreement with POINT Biopharma Inc.
5th Jan 2021 11:05 am RNS Second Price Monitoring Extn
5th Jan 2021 11:00 am RNS Price Monitoring Extension
23rd Dec 2020 7:00 am RNS Submission of CTA for AVA6000 Pro-doxorubixin
21st Dec 2020 7:00 am RNS License Agreement with Astrea Bioseparations
23rd Nov 2020 9:05 am RNS Second Price Monitoring Extn
23rd Nov 2020 9:00 am RNS Price Monitoring Extension
23rd Nov 2020 7:00 am RNS SARS-CoV-2 Rapid Antigen Test Update
18th Nov 2020 4:40 pm RNS Second Price Monitoring Extn
18th Nov 2020 4:36 pm RNS Price Monitoring Extension
13th Nov 2020 2:15 pm RNS Issue of Equity
10th Nov 2020 11:06 am RNS Second Price Monitoring Extn
10th Nov 2020 11:00 am RNS Price Monitoring Extension
9th Nov 2020 2:06 pm RNS Second Price Monitoring Extn
9th Nov 2020 2:01 pm RNS Price Monitoring Extension
22nd Oct 2020 1:50 pm RNS Director/PDMR Shareholding
8th Oct 2020 9:00 am RNS Issue of Equity
30th Sep 2020 2:05 pm RNS Second Price Monitoring Extn
30th Sep 2020 2:00 pm RNS Price Monitoring Extension
30th Sep 2020 10:35 am RNS Launch of SARS-CoV-2 BAMS Research Test
29th Sep 2020 7:00 am RNS Appointment of Joint Broker
28th Sep 2020 9:00 am RNS Price Monitoring Extension
28th Sep 2020 7:00 am RNS Interim Results for the Period Ended 30 June 2020
24th Sep 2020 7:00 am RNS Update on Integumen Collaboration
14th Sep 2020 7:00 am RNS Notice of Results and Investor Presentation
7th Sep 2020 7:00 am RNS Avacta to Launch SARS-CoV-2 ELISA Laboratory Test
2nd Sep 2020 7:00 am RNS Expansion of COVID-19 Test Manufacturing Capacity
20th Aug 2020 4:45 pm RNS Issue of Equity
19th Aug 2020 4:41 pm RNS Second Price Monitoring Extn
19th Aug 2020 4:36 pm RNS Price Monitoring Extension
19th Aug 2020 2:05 pm RNS Second Price Monitoring Extn
19th Aug 2020 2:00 pm RNS Price Monitoring Extension
18th Aug 2020 3:30 pm RNS Issue of Equity
18th Aug 2020 7:00 am RNS Expanded Partnership with LG Chem Life Sciences
17th Aug 2020 7:00 am RNS Clarification Regarding Medusa 19 Antibody Test
11th Aug 2020 9:30 am RNS Holding(s) in Company
11th Aug 2020 7:00 am RNS Therapeutics Chief Development Officer Appointment
FTSE 100 Latest
Value8,850.63
Change-34.29